900 reports

  • HIGHLIGHTS

Ado-trastuzumab emtansine (Kadcyla, ), an antibody that targets HER##, attaches itself to a chemo drug called Myotonic dystrophy type ## (DM##).

  • Monoclonal Antibody
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • VERSATILITY OF PIPELINE PRODUCTS ACROSS THERAPY AREAS, INDICATIONS AND TARGETS
  • MABS MARKET, GLOBAL, ANNUAL REVENUE FOR OPDIVO, 2014-2023

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape Summary Antibodies, otherwise known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by immune cells in response to pathogens such as bacteria and viruses. They consist of two large heavy polypeptide chains and...

  • Monoclonal Antibody
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson
  • IV. MONOCLONAL ANTIBODY PRODUCTION AND
  • Demand of Monoclonal Antibody by Region

China’s demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Monoclonal Antibody
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • Demand of Monoclonal Antibody by Region
  • IV. MONOCLONAL ANTIBODY PRODUCTION AND

This study focuses on China’s Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Monoclonal Antibody
  • China
  • Demand
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Monoclonal Antibody
  • Therapy
  • World
  • Market Shares
  • Market Size

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts Executive Summary Chapter ## – Introduction Chapter ## – Trends in Cancer monoclonal antibody dealmaking ##. ##.

  • Monoclonal Antibody
  • Therapy
  • World
  • Demand
  • Monoclonal Antibody Sales Volume
  • Monoclonal Antibody Production

This study focuses on China’s Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...

  • Monoclonal Antibody
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Roche Group
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • ANTI-CANCER MABS ACT AGAINST MALIGNANT CELLS THROUGH THE MECHANISMS MENTIONED IN THE EXHIBIT BELOW.
  • EXECUTIVE SUMMARY

About Monoclonal Antibodies Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific,...

  • Monoclonal Antibody
  • World
  • Market Size
  • AbbVie Inc.
  • Amgen Inc.

The 2019-2024 World Outlook for Biosimilar Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Rheumatoid Arthritis (RA) Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

Monoclonal Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024 ##.

  • Monoclonal Antibody
  • Pharmaceutical
  • APAC
  • World
  • Market Size
  • SCOPE OF THE REPORT
  • KEY NEWS

ADCETRIS is a chimeric monoclonal immunoglobulin (Ig)G## antibody, which acts against CD## expressed in HL and systemic anaplastic large cell lymphoma.

  • Monoclonal Antibody
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

The Development of Therapeutic Monoclonal Antibody Products CHAPTER ##: The Therapeutic Monoclonal Antibody Market ## CHAPTER ##: Overview of Chemistry, Manufacturing, and Control Activities for Monoclonal Antibody Product Developm

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • Demand
  • MONOCLONAL ANTIBODIES (MABS)
  • Global Monoclonal Antibodies Market, 2017, By Therapeutic Area

Biologics Global Market Opportunities And Strategies By Product Type: Monoclonal Antibodies (mAbs), Therapeutic Proteins and Vaccines; By Region, By Country, With Forecast Until 2021 The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human...

  • Monoclonal Antibody
  • World
  • Market Size
  • AbbVie Inc.
  • Sanofi S.A.
  • MONOCLONAL ANTIBODIES (MABS)
  • Global Monoclonal Antibodies Market, 2017, By Therapeutic Area

The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes.Biologics products include a wide range of recombinant therapeutic proteins, vaccines, and monoclonal antibodies. These products are isolated from natural sources such as human, animal, and...

  • Monoclonal Antibody
  • World
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.

Each monoclonal antibody recognizes one particular protein.

  • Monoclonal Antibody
  • Therapy
  • APAC
  • World
  • Market Size
  • 6.1 MONOCLONAL ANTIBODIES
  • Middle East & African Biosimilar Market, Monoclonal Antibodies,

The global biosimilar market was estimated to be valued at USD 3,474.01 million in 2017, and is expected to register a CAGR of 43.85% during the forecast period of 2018-2023. North America accounted for the largest share of approximately 30% of the global market, in 2017, while Asia-Pacific region is anticipated to register the highest CAGR...

  • Monoclonal Antibody
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024 Table of Contents Chapter

  • Monoclonal Antibody
  • United States
  • Demand
  • Market Size
  • Supply

Biosimilar Monoclonal Antibodies Market Forecast 2016-2026: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab ##.

  • Monoclonal Antibody
  • Therapy
  • World
  • Market Shares
  • Market Size
  • 7.1.1.2 ANTI-INFLAMMATORY MONOCLONAL ANTIBODIES
  • 7.1.1.3 OTHER MONOCLONAL ANTIBODIES

The global biopharmaceuticals market is estimated to reach USD 341.16 billion in 2023. The market is expected to register a CAGR of 8.5% during the forecast period (2018 – 2023). North America dominates the market due to rapid technological advancements. Increasing Acceptance for Biopharmaceuticals and Significant Market Demand Opportunities...

  • Biopharmaceutical
  • Biotechnology
  • Monoclonal Antibody
  • World
  • Market Size

& nbsp; Chapter ##: Introduction Study Goals and Objectives Monoclonal antibodies are a type of bioengineered protein drugs.

  • Monoclonal Antibody
  • Therapy
  • World
  • Market Shares
  • Monoclonal Antibody Sales Volume (million Yuan)
  • Monoclonal Antibody Sales Volume (million Yuan)

This study focuses on China’s Kidney Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Monoclonal Antibody
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Monoclonal Antibody Sales Volume (million Yuan)
  • Monoclonal Antibody Sales Volume (million Yuan)

China’s demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Monoclonal Antibody
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Source: GBI Research Proprietary Pipeline Product Database, GBI Research Analysis Abbreviations: mAb: monoclonal Antibody
  • Prostaglandinsand receptors

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis Summary Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of dermatological conditions are thought to exist,...

  • Monoclonal Antibody
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Source: GBI Research, company reported data, analyst consensus Abbreviations: mAb: monoclonal antibody
  • Source: GBI Research, company reported data, analyst consensus Abbreviations: mAb: monoclonal antibody; TNF: tumor necrosis factor

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Gastrointestinal disorders are common, and a number of them have a large patient population. Across the seven major markets (the US, the UK, France,...

  • Monoclonal Antibody
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • Source: GBI Research Proprietary Deals Database, GBI Research Analysis Abbreviations: mAb: monoclonal antibody; NA: not available
  • GENETHERAPY

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market Summary Psoriasis is a chronic, autoimmune, relapsing, inflammatory disease triggered by deregulated thymus-derived cells (T cells), resulting in inflammation...

  • Monoclonal Antibody
  • World
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.